Diabetes UK is delighted to announce its continued support of the National Prevention Research Initiative (NPRI), which funds research aimed at improving health and preventing diseases or conditions such as diabetes, cancer, obesity, stroke and dementia.
The Initiative, which was established in 2004, supports research on behaviours associated with health risks such as smoking, alcohol consumption, diet and exercise, and on the environmental factors that influence these behaviours.
£10m available to UK researchers
Seventeen government departments, research organisations and charities have backed the fourth phase of the Medical Research Council’s venture, which is making £10m available to UK researchers to develop and test interventions to encourage people to make long-term behaviour changes. Diabetes UK is contributing £125,000 over five years towards the fourth phase of the NPRI.
Dr Iain Frame, Director of Research at Diabetes UK, said: "Diabetes UK has contributed financially to the NRPI since its formation, and is delighted to continue to do so. The Initiative is a great opportunity for us to join forces with other health and medical research funders, and to maximise the return we get on our investments. As we’ve seen in the first three phases of the NPRI, the impact of this research will be felt across many long-term conditions, including diabetes.
"Funding like this is key to encourage and enable researchers from various disciplines to collaborate and gather the evidence we need to improve people’s health by influencing health policy in the UK."
The deadline for submitting outline applications is 4pm on November 3, 2010. Only short-listed applicants will be entitled to submit a full application. Further details are available atwww.npri.org.uk.
Phase 4 of the NPRI is funded through a partnership of the following organisations: Alzheimer’s Research Trust; Alzheimer’s Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health & Social Care Research & Development Office for Northern Ireland; Medical Research Council; The Stroke Association; Wellcome Trust; Welsh Assembly Government; and World Cancer Research Fund.